MLP Sağlık Hizmetleri A.Ş. (MLP Care) has signed a protocol and initiated negotiations to acquire 100% of the shares of Bileşim Turizm İnşaat Sanayi ve Ticaret A.Ş., which owns Private Gaziosmanpaşa Hospital, one of the leading private hospitals in Istanbul in terms of enclosed area, bed capacity, and number of physicians. Negotiations regarding the transaction have commenced. The process is expected to be completed within two months at the latest.
Founded in 1992, Özel Gaziosmanpaşa Hospital has grown into a reputable and established healthcare institution through continuous development by its founders. With approximately 60 thousand square meters of enclosed area and 403 beds, the hospital ranks among the top five out of 576 private hospitals in Türkiye based on bed and physician capacity. Furthermore, it is classified as a tertiary care private hospital, which represents only around 2% of all private hospitals in Türkiye.
Upon completion of the share transfer, the transaction is expected to contribute significantly to the Company`s inorganic growth in terms of bed capacity and physician base. Based on its licensed bed capacity, variety of departments, number of specialized centers, and high number of physicians, the hospital is expected to rank among the top two within the MLP Care network.
Considering these characteristics, the integration of this hospital into our group is expected to generate significant synergies and will represent one of the most strategic acquisitions carried out by our Company to date.
The public disclosure of this transaction had previously been postponed by the resolution of our Board of Directors in accordance with Article 6 of the Capital Markets Board`s Material Events Communiqué (II-15.1), in order to prevent possible adverse effects on the process, to protect the Company`s legitimate rights and interests, and to ensure that the transaction would proceed fairly, transparently, and impartially. This announcement has been made as the reasons for postponement have ceased to exist. Further material developments regarding the process will continue to be shared with our investors.
This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail.
